Treatment Pathway
Treatment of Strongyloidiasis
Strongyloidiasis is caused by Strongyloides stercoralis, a soil-transmitted nematode capable of autoinfection and chronic persistence for decades. In immunocompromised patients, hyperinfection syndrome can be life-threatening. Ivermectin is the treatment of choice.
WHO Global Antimicrobial GuidelinesIDSA (Infectious Diseases Society of America)NICE (UK)ECDC (European Centre for Disease Prevention)Surviving Sepsis Campaign
Strongyloidiasis is caused by Strongyloides stercoralis, a soil-transmitted nematode capable of autoinfection and chronic persistence for decades. In immunocompromised patients, hyperinfection syndrome can be life-threatening. Ivermectin is the treatment of choice.
First-Line Treatment Principles
- ✓Identify pathogen and antimicrobial sensitivities before initiating targeted therapy
- ✓De-escalate antimicrobial spectrum as soon as culture/sensitivity results available
- ✓Source control: drainage of abscesses, removal of infected catheters/prosthetics
- ✓Empirical antibiotics: cover likely pathogens based on clinical syndrome and local resistance patterns
- ✓Adhere to minimum effective duration to reduce resistance selection
Medications Used in Strongyloidiasis
Non-Pharmacological Management
- •Infection prevention: hand hygiene, vaccination, insect bite prevention (malaria/dengue/Lyme)
- •Isolation precautions for highly contagious or drug-resistant organisms
- •Nutritional support: adequate protein and calorie intake during infectious illness
- •Rest and adequate hydration during acute illness
- •Vector control for vector-borne diseases (mosquito nets, repellents, chemoprophylaxis for travel)
- •Contact tracing for notifiable diseases (TB, meningococcal, sexual infections)
Treatment Goals
🎯Microbiological eradication: negative cultures, resolution of pathogen-specific markers
🎯Clinical cure: resolution of fever, inflammatory markers, and organ dysfunction
🎯Prevention of complications: abscess formation, septicaemia, chronic infection
🎯Minimise antimicrobial resistance development through appropriate stewardship
🎯Return to full functional capacity and prevention of recurrence
Monitoring Parameters
- ◆Temperature, heart rate, respiratory rate, and blood pressure: 4-hourly in hospital
- ◆CRP, procalcitonin: inflammation markers to guide treatment response and de-escalation
- ◆Blood cultures: before antibiotics if systemic infection suspected; repeat if deterioration
- ◆Organ function: LFTs, renal function, FBC — especially with prolonged therapy
- ◆Antimicrobial drug levels (vancomycin, aminoglycosides) to optimise dosing and prevent toxicity
- ◆Clinical response at 48–72h: reassess empirical therapy if no improvement
Escalation Criteria
- →Sepsis/septic shock: immediate IV broad-spectrum antibiotics within 1 hour; ICU admission
- →Clinical deterioration at 48–72h despite appropriate antibiotics → reassess diagnosis, obtain cultures, consider resistant organisms
- →Drug-resistant organism identified → infectious disease specialist review
- →Immunocompromised host: lower threshold for escalation; consider uncommon pathogens (fungal, mycobacterial)
Special Populations
Immunocompromised: HIV, transplant, chemotherapy patients need broader empirical coverage and lower threshold for invasive investigation
Pregnancy: many antibiotics restricted (fluoroquinolones, tetracyclines, aminoglycosides) — seek specialist guidance
Children: weight-based dosing; higher suspicion for unusual organisms (meningococcal in adolescents, Haemophilus in unvaccinated)
Elderly: impaired immune response; higher risk of drug toxicity; atypical presentations (confusion as only sign)
Clinical Insights
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →